CoChat

The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var)3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 Å resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0165139

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 MLL5 SET domain lacks important residues for methyltransferase activity. (A). Sequence alignment of the human MLL5 SET domain with SET domains from other methyltransferases (human SETD5, Drosophila UPSET, yeast SET3, yeast SET1, human MLL1, human MLL3, human ASH1L, human SET7/9, human GLP, human DIM5 and human NSD1). Structural alignment was calculated using the Dali server [56] when structure of the SET domain were available. Protein subdomains, indicated above the sequences, are based on the human MLL1 SET domain [14]. Secondary structure elements, derived from the structure of the MLL5 SET domain, are also shown above the sequences. Residues usually important for cofactor binding (dark blue) and for substrate binding and maintenance in the active center (cyan) are highlighted. Conserved cysteines from the zinc-binding cage are underlined. (B). Phylogenetic tree of methyltransferases related to MLL5 using sequences from humans (Homo sapiens) (Hs, black), the cephalochordate amphioxus (Branchiostoma floridae) (Bf, blue), the fruit fly (Drosophila melanogaster) (Dm, green) and the yeast (Saccharomyces cerevisiae) (Sc, red). The tree resulting from the Maximum Likelihood (ML) analysis is shown and branch lengths are representative of sequence substitution rates. Branch support is indicated as Bootstrap percentages (ranging from 0 to 100) and as posterior probabilities (ranging from 0 to 1) obtained from the Bayesian Inference (BI) analysis (provided in parentheses at each node). “(—)” indicates that the branching patterns of the ML and BI analyses diverged at this node and that a posterior probability score is thus unavailable.
Fig 1 MLL5 SET domain lacks important residues for methyltransferase activity. (A). Sequence alignment of the human MLL5 SET domain with SET domains from other methyltransferases (human SETD5, Drosophila UPSET, yeast SET3, yeast SET1, human MLL1, human MLL3, human ASH1L, human SET7/9, human GLP, human DIM5 and human NSD1). Structural alignment was calculated using the Dali server [56] when structure of the SET domain were available. Protein subdomains, indicated above the sequences, are based on the human MLL1 SET domain [14]. Secondary structure elements, derived from the structure of the MLL5 SET domain, are also shown above the sequences. Residues usually important for cofactor binding (dark blue) and for substrate binding and maintenance in the active center (cyan) are highlighted. Conserved cysteines from the zinc-binding cage are underlined. (B). Phylogenetic tree of methyltransferases related to MLL5 using sequences from humans (Homo sapiens) (Hs, black), the cephalochordate amphioxus (Branchiostoma floridae) (Bf, blue), the fruit fly (Drosophila melanogaster) (Dm, green) and the yeast (Saccharomyces cerevisiae) (Sc, red). The tree resulting from the Maximum Likelihood (ML) analysis is shown and branch lengths are representative of sequence substitution rates. Branch support is indicated as Bootstrap percentages (ranging from 0 to 100) and as posterior probabilities (ranging from 0 to 1) obtained from the Bayesian Inference (BI) analysis (provided in parentheses at each node). “(—)” indicates that the branching patterns of the ML and BI analyses diverged at this node and that a posterior probability score is thus unavailable.CC BY · PubMed Central
Fig 2 Absence of cofactor and substrate (H3K4 peptide) binding to the MLL5 SET domain. (A). Isothermal titration calorimetry shows that the MLL5 SET domain in combination with the N-terminal flanking helix and the POSTSET does not bind the cofactor S-adenosyl methionine (SAM). Results were the same with the fragment SET-POSTSET. (B). Fluorescence anisotropy shows that the MLL5 SET domain (SET-POSTSET construct) does not bind either the non-methylated or mono-methylated H3K4 peptide. (C). 1H NMR spectra of SET-POSTSET construct and un-methylated H3K4 peptide. Upper panel: Expansion of 1H NMR spectra of un-methylated H3K4 peptide (top) at 400 μM, and in presence of different ratios protein/peptide (1:20, 1:10, 1:5). Lower panel: Expansion of 1H (top) and saturation transfer difference (STD) spectra of un-methylated H3K4 peptide at 400 μM in presence of different ratios of protein. In all spectra, the fine peak labeled with an asterisk (*), if present, corresponds to an impurity, whose resonance is imperfectly subtracted in STD on- and off-resonance experiments.
Fig 2 Absence of cofactor and substrate (H3K4 peptide) binding to the MLL5 SET domain. (A). Isothermal titration calorimetry shows that the MLL5 SET domain in combination with the N-terminal flanking helix and the POSTSET does not bind the cofactor S-adenosyl methionine (SAM). Results were the same with the fragment SET-POSTSET. (B). Fluorescence anisotropy shows that the MLL5 SET domain (SET-POSTSET construct) does not bind either the non-methylated or mono-methylated H3K4 peptide. (C). 1H NMR spectra of SET-POSTSET construct and un-methylated H3K4 peptide. Upper panel: Expansion of 1H NMR spectra of un-methylated H3K4 peptide (top) at 400 μM, and in presence of different ratios protein/peptide (1:20, 1:10, 1:5). Lower panel: Expansion of 1H (top) and saturation transfer difference (STD) spectra of un-methylated H3K4 peptide at 400 μM in presence of different ratios of protein. In all spectra, the fine peak labeled with an asterisk (*), if present, corresponds to an impurity, whose resonance is imperfectly subtracted in STD on- and off-resonance experiments.CC BY · PubMed Central
Fig 3 The MLL5 SET domain does not possess histone methyltransferase (HMT) activity. Radioactive HMT assays were performed with the bacterially purified Nh-SET-POSTSET fragment and histones from calf thymus as substrate. Recombinant proteins were incubated with HeLa nuclear extracts (+ NE) or not. SET7 was used as positive control (set as 100% activity) and the same condition in absence of any enzyme was used as negative control (Control).
Fig 3 The MLL5 SET domain does not possess histone methyltransferase (HMT) activity. Radioactive HMT assays were performed with the bacterially purified Nh-SET-POSTSET fragment and histones from calf thymus as substrate. Recombinant proteins were incubated with HeLa nuclear extracts (+ NE) or not. SET7 was used as positive control (set as 100% activity) and the same condition in absence of any enzyme was used as negative control (Control).CC BY · PubMed Central
Fig 4 Crystal structure of the MLL5 SET domain highlights unexpected feature. (A). The structure is represented as a cartoon model and secondary structure elements are labeled. The subdomains are: SET-N in pale green, SET-I in blue, SET-C in bright green and the beginning of the POSTSET domain in yellow. (B). Part of the MLL5-SET (dark grey), DIM-5-SET (cyan, PDB entry 1PEG) and SET7/9-SET (light orange, PDB entry 1O9S) domains are superimposed and represented by cartoons. The histone peptide in complex with the SET7/9-SET-domain is colored in orange. The loop of the MLL5-SET domain occupies the region of the substrate binding groove (highlighted in a circle). (C). Groove of K4 peptide binding of MLL3 (pink surface, PDB entry 5F6K) superimposed with the MLL5 structure (cyan) to highlight the occupation of the substrate groove by the MLL5 loop between α1 and β5. (D). Zoom-out view of the interface (salt-bridge and hydrogen bonds as well as hydrophobic stacking between aromatic residues shown as dashed lines) that maintains the loop between α1 and β5 in the peptide groove.
Fig 4 Crystal structure of the MLL5 SET domain highlights unexpected feature. (A). The structure is represented as a cartoon model and secondary structure elements are labeled. The subdomains are: SET-N in pale green, SET-I in blue, SET-C in bright green and the beginning of the POSTSET domain in yellow. (B). Part of the MLL5-SET (dark grey), DIM-5-SET (cyan, PDB entry 1PEG) and SET7/9-SET (light orange, PDB entry 1O9S) domains are superimposed and represented by cartoons. The histone peptide in complex with the SET7/9-SET-domain is colored in orange. The loop of the MLL5-SET domain occupies the region of the substrate binding groove (highlighted in a circle). (C). Groove of K4 peptide binding of MLL3 (pink surface, PDB entry 5F6K) superimposed with the MLL5 structure (cyan) to highlight the occupation of the substrate groove by the MLL5 loop between α1 and β5. (D). Zoom-out view of the interface (salt-bridge and hydrogen bonds as well as hydrophobic stacking between aromatic residues shown as dashed lines) that maintains the loop between α1 and β5 in the peptide groove.CC BY · PubMed Central
Fig 5 Dynamic properties of the unliganded MLL5 SET domain. The root mean square fluctuations (RMSF) of the SET domain residues during 100 ns of MD simulation are shown in red. The equivalent plot for the MLL3 SET domain isolated, taken from [16] and whose data where kindly sent by Y. Zhang, is shown in black.
Fig 5 Dynamic properties of the unliganded MLL5 SET domain. The root mean square fluctuations (RMSF) of the SET domain residues during 100 ns of MD simulation are shown in red. The equivalent plot for the MLL3 SET domain isolated, taken from [16] and whose data where kindly sent by Y. Zhang, is shown in black.CC BY · PubMed Central
Fig 6 The S-adenosylmethionine (SAM) binding motif is not present and the active site is incomplete in the MLL5 SET domain. (A). Superposition of the motif RRS of MLL5 SET domain (black and gray sticks), the motif NHS of SET7/9 SET domain in its apo (pink, PDB entry 1H3I) form and in ternary complex (orange, PDB entry 1O9S) and of the motif RKA of PRDM4 SET domain (green, PDB entry 3DB5). (B). Residues of the MLL3 SET domain (PDB entry 5F6K, green sticks) forming hydrogen bonds with the cofactor SAM (yellow sticks). Corresponding residues of the MLL5 SET domain are superimposed (cyan sticks). (C). Superimposition of MLL5 residues (cyan sticks) and the MLL3 active site (PDB entry 5F6K, green sticks). Hydrogen bonds stabilizing the histone peptide (yellow sticks) are shown as dashed lines.
Fig 6 The S-adenosylmethionine (SAM) binding motif is not present and the active site is incomplete in the MLL5 SET domain. (A). Superposition of the motif RRS of MLL5 SET domain (black and gray sticks), the motif NHS of SET7/9 SET domain in its apo (pink, PDB entry 1H3I) form and in ternary complex (orange, PDB entry 1O9S) and of the motif RKA of PRDM4 SET domain (green, PDB entry 3DB5). (B). Residues of the MLL3 SET domain (PDB entry 5F6K, green sticks) forming hydrogen bonds with the cofactor SAM (yellow sticks). Corresponding residues of the MLL5 SET domain are superimposed (cyan sticks). (C). Superimposition of MLL5 residues (cyan sticks) and the MLL3 active site (PDB entry 5F6K, green sticks). Hydrogen bonds stabilizing the histone peptide (yellow sticks) are shown as dashed lines.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. A Sali, 2008, MODELLER A Program for Protein Structure Modeling Release 9v4, r6262, Structure, 779

Cited by

See all 43

Metadata

Authors
Mas-y-Mas, S., Barbon, M., Teyssier, C., Déméné, H., Carvalho, J. E., Bird, L. E., Lebedev, A., Fattori, J., Schubert, M., Dumas, C., Bourguet, W., & le Maire, A.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Université de Montpellier (FR)
  • Rutherford Appleton Laboratory (GB)
  • Brazilian Center for Research in Energy and Materials (BR)
Venue
PLOS ONE
Published
2016-11-03
Volume
11
Issue
11
Pages
e0165139
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2546928489
Cited by
43
References
62
Citations by year
2026: 3 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 9 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 7
FWCI
2.42
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Science and Technology Facilities Council (submittedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • Fundação para a Ciência e a Tecnologia (SFRH/BD/86878/2012)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
MLL5, SET domain, crystal structure, histone H3, plant homeodomain, histone methyltransferase activity, cofactor binding, chromatin binding, hematopoiesis, spermatogenesis, cell cycle regulation
MeSH terms
Protein Domains, Amino Acid Sequence, DNA-Binding Proteins, Humans, Models, Molecular, Crystallography, X-Ray, Biocatalysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity. https://app.cochat.ai/papers/10.1371/journal.pone.0165139
The paper
Mas-y-Mas, S., Barbon, M., Teyssier, C., Déméné, H., Carvalho, J. E., Bird, L. E., Lebedev, A., Fattori, J., Schubert, M., Dumas, C., Bourguet, W., & le Maire, A. (2016). The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity. PLOS ONE. https://doi.org/10.1371/journal.pone.0165139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.